drugset

drugset / Trial / NCT02308046

Multi-Center Study of New Medications to Treat Vaginal Infections

NCT02308046 ↗

Phase 3 Completed 212 enrolled Curatek Pharmaceuticals, LLC

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to evaluate the safety and efficacy of terconazole gel in the treatment of vaginal infections

Timeline

Start: 2015-06
Primary completion: 2017-06
Completion: 2017-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Terconazole	Small molecule	—	—

Indications